On demand Conference: January 19 – March 2, 2021
Live Conference: January 28-31, 2021
https://myelodysplastic-syndromes-2021.esh.live/
Copyrights
E-Conference participants are requested to treat the information presented during ESH meetings as privileged
communication.
Presentation of data during ESH E-Conferences does not constitute publication in the sense of patent law and the data
presented therefore retains unpublished status.
Ask the faculty:
The E-Conference platform allows you to submit your question online.
Simply use the “ask a question” field when viewing the presentations / discussions
Twitter:
Contribute to the Twitter discussion online using #ESHMDS2021
CME Accreditation:
The programme of the ESH Translational Research E-Conference on Myelodysplastic Syndromes 2021 has been reviewed and
approved for CME accreditation by the European Board for Accreditation in Haematology (EBAH). The EHA-CME Unit has
approved this educational activity for a maximum number of 17 CME credits. Each physician should only claim credits for
time that she/he actually spent in the educational activity.
The Translational Research E-Conference on Myelodysplastic Syndromes 2021 is committed to providing unbiased, balanced
and objective educational and scientific programmes. In accordance with EBAH guidelines, all planners and speakers are
asked to provide disclosures of their relevant financial relationships, which are available for audience review via a slide
presentation. The CME provider has a mechanism in place to identify and resolve any conflicts of interest prior to the start of
each presentation. Audience members will be asked to assess each presentation for the presence/absence of commercial
bias.
SCIENTIFIC PROGRAMME
SESSION I
ETIOLOGY OF MDS
SESSION II
BIOLOGY OF MDS –
GENETIC ABNORMALITIES
SESSION III
BIOLOGY OF MDS:
STEM CELLS AND THE
MICROENVIRONMENT
SESSION IV
DIAGNOSTIC WORKUP
AND PROGNOSTIC
FACTORS IN MDS
SESSION V
SPECIFIC SUBTYPES
OF MDS, BASED ON
MORPHOLOGY AND
MOLECULAR BIOLOGY
SESSION VI
TREATMENT OF MDS
SESSION VII
CURRENT PROGRESS IN
THE TREATMENT OF MDS
SESSION VIII
FUTURE TREATMENTS
AND TREATMENT
STRATEGIES IN MDS
SESSION IX
LATE-BREAKING TALKS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
AS E-POSTERS
DISCLOSURES